Neuroscientists are pretty sure they know what causes Alzheimer's disease, but their theory has not yet given rise to effective drugs. Alison Abbott asks what's wrong.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Ferri, C. P. et al. Lancet 366, 2112–2117 (2005).
Holmes, C. et al. Lancet 372, 216–233 (2008).
Lippa, C. F., Nee, L. E., Mori, H. & St George-Hyslop, P. Lancet 352, 1117–1118 (1998).
Roberson, E. D. et al. Science 316, 750–754 (2007).
Ikonomovic, M. D. et al. Brain 131, 1630–1645 (2008).
Dubois, B. et al. Lancet Neurol. 6, 734–746 (2007).
Ledford, H. Nature 452, 510–511 (2008).
Additional information
Alison Abbott is Nature's senior European correspondent.
Related links
Related links
Related links in Nature Research
Related external links
EMEA guidelines on Alzheimer's disease
The EU Alzheimer Biomarker programme (AddNeuroMed)
Rights and permissions
About this article
Cite this article
Abbott, A. Neuroscience: The plaque plan. Nature 456, 161–164 (2008). https://doi.org/10.1038/456161a
Published:
Issue Date:
DOI: https://doi.org/10.1038/456161a
This article is cited by
-
Intranasal Lactoferrin Enhances α-Secretase-Dependent Amyloid Precursor Protein Processing via the ERK1/2-CREB and HIF-1α Pathways in an Alzheimer’s Disease Mouse Model
Neuropsychopharmacology (2017)
-
Aging of perennial cells and organ parts according to the programmed aging paradigm
AGE (2016)
-
Neurovascular function in Alzheimer's disease patients and experimental models
Journal of Cerebral Blood Flow & Metabolism (2011)
-
γ-Secretase-Regulated Mechanisms Similar to Notch Signaling May Play a Role in Signaling Events, Including APP Signaling, Which Leads to Alzheimer’s Disease
Cellular and Molecular Neurobiology (2011)
-
Activity-Dependent Neuroprotective Protein (ADNP) Expression in the Amyloid Precursor Protein/Presenilin 1 Mouse Model of Alzheimer’s Disease
Journal of Molecular Neuroscience (2010)